mRNA

Mainz-virksomheden har truffet sin første strategiske beslutning efter stifternes afgang og fastholder mRNA-teknologien.

28. oktober 2025 Rapporteret af AI Faktatjekket

A large retrospective study from the University of Florida and The University of Texas MD Anderson Cancer Center, published in Nature, reports that patients with advanced non-small cell lung cancer or metastatic melanoma lived significantly longer if they received a Pfizer-BioNTech or Moderna COVID-19 mRNA shot within 100 days of starting immune checkpoint inhibitors. The authors stress the findings are observational and will require confirmation in randomized trials.